ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

SMMT Summit Therapeutics Inc

4.39
0.00 (0.00%)
시간외 단일가
최종 업데이트: 20:00:08
15분 지연
기업명 주식 심볼 시장 주식 타입
Summit Therapeutics Inc SMMT 나스닥 주식예탁증서 (DR)
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.00 0.00% 4.39 20:00:08
개장가 저가 고가 종가 전일 종가
4.39
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
01/05/202420:00BWSummit Therapeutics Reports Financial Results and..
25/04/202405:30BWSummit Therapeutics to Host First Quarter 2024 Financial..
12/04/202405:30BWSummit Therapeutics Appoints Dr. Mostafa Ronaghi, Renowned..
10/04/202420:00BWSummit Therapeutics to Present at the Stifel 2024 Targeted..
22/03/202420:00BWPromising Intracranial Anti-Tumor Activity and Safety Data..
14/03/202420:00BWIntracranial Anti-Tumor Activity and Safety of Ivonescimab..
06/03/202406:05EDGAR2Form 8-K - Current report
05/03/202421:00BWSummit Therapeutics to Present at the Barclays 26th Annual..
20/02/202422:05EDGAR2Form 8-K - Current report
20/02/202421:55EDGAR2Form S-3 - Registration statement under Securities Act of..
20/02/202421:32EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
20/02/202421:00BWSummit Therapeutics Reports Financial Results and..
16/02/202407:25EDGAR2Form 8-K - Current report
15/02/202406:35EDGAR2Form 5 - Annual statement of changes in beneficial ownership..
15/02/202400:29BWSummit Therapeutics to Host Fourth Quarter & Full Year 2023..
14/02/202421:00BWSummit Therapeutics to Host Fourth Quarter & Full Year 2023
07/02/202421:00BWSummit Therapeutics to Present at Oppenheimer’s 34th Annual..
08/01/202423:07EDGAR2Form 8-K - Current report
08/01/202423:00BWSummit Therapeutics Announces Updated Phase II Data for..
05/01/202406:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/01/202406:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/01/202406:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/01/202406:06EDGAR2Form 8-K - Current report
03/01/202421:30BWSummit Therapeutics to Present at the 42nd Annual J.P...
14/12/202306:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/11/202322:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202322:03EDGAR2Form 8-K - Current report
07/11/202321:00BWSummit Therapeutics Reports Financial Results and..
03/11/202305:41BWLaura Chow, MD, Cancer Immunotherapy Trailblazer, Joins..
01/11/202305:02EDGAR2Form 8-K - Current report
31/10/202321:00BWIvonescimab’s Novel Mechanism of Action Highlighting..
26/10/202321:00BWSummit Therapeutics to Host Q3 2023 Financial Results &..
19/10/202321:00BWH. Jack West, MD, Renowned Oncologist & Lung Cancer Expert,..
16/10/202320:46EDGAR2Form 8-K - Current report
16/10/202320:00BWSummit Therapeutics Appoints Proven Biotech Leader Manmeet..
20/09/202304:40EDGAR2Form DEF 14A - Other definitive proxy statements
09/09/202305:08EDGAR2Form PRE 14A - Other preliminary proxy statements
10/08/202305:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/08/202321:03EDGAR2Form 8-K - Current report
09/08/202320:00BWSummit Therapeutics Reports Financial Results and..
03/08/202305:05EDGAR2Form 8-K - Current report
02/08/202321:00BWSummit Therapeutics to Host Q2 2023 Financial Results &..
04/06/202321:00BWPromising Data for Investigational Innovative Bispecific..
01/06/202320:30BWIvonescimab Updated Data to be Featured at ASCO 2023
11/05/202320:30BWSummit Therapeutics Reports Financial Results and..
09/05/202320:30BWSummit Therapeutics Announces First Patient Treated in Phase..

최근 히스토리

Delayed Upgrade Clock